Who owns SENTI BIOSCIENCES INC?
- Ticker: SNTI
- CUSIP Number: 81726a209
Tip: Access positions for across all investors
Analyze quarterly positions in Senti Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Senti Biosciences stock
Who bought or sold SENTI BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 3.8M | $5.3M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 888k | $1.3M | 0% | Sep 2025 |
|
| Vanguard Group | 616k | $869k | 71% | Sep 2025 |
|
| Geode Capital Management | 153k | $216k | 4% | Sep 2025 |
|
| Citadel Advisors | 83k | $117k | 100% | Sep 2025 |
|
| XTX Topco | 27k | $38k | 100% | Sep 2025 |
|
| BlackRock | 23k | $32k | 2% | Sep 2025 |
|
| Northern Trust | 16k | $23k | 100% | Sep 2025 |
|
| Two Sigma Investments | 16k | $23k | 100% | Sep 2025 |
|
| State Street Corporation | 10k | $14k | 0% | Sep 2025 |
|
| Tower Research Capital | 1.7k | $2.4k | 54% | Sep 2025 |
|
| SBI Securities | 336.00 | $473.995200 | -1% | Sep 2025 |
|
| Morgan Stanley | 160.00 | $338.000000 | 100% | Jun 2025 |
|
Who sold out of Senti Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Heights Capital Management | Jun 2025 | 381k | $805k |
| UBS Group | Jun 2025 | 4.4k | $9.3k |
| Barclays | Jun 2025 | 569.00 | $1.0k |